WallStSmart

Alcon AG (ALC)vsStereotaxis Inc (STXS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alcon AG generates 32025% more annual revenue ($10.40B vs $32.38M). ALC leads profitability with a 9.4% profit margin vs -66.8%. STXS appears more attractively valued with a PEG of 1.31. ALC earns a higher WallStSmart Score of 49/100 (D+).

ALC

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 5.0Value: 7.3Quality: 7.3
Piotroski: 4/9

STXS

Avoid

34

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-489.8%)

Margin of Safety

-489.8%

Fair Value

$13.46

Current Price

$75.26

$61.80 premium

UndervaluedFair: $13.46Overvalued

Intrinsic value data unavailable for STXS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

STXS1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
36.3%10/10

Revenue surging 36.3% year-over-year

Areas to Watch

ALC4 concerns · Avg: 3.3/10
PEG RatioValuation
1.704/10

Expensive relative to growth rate

P/E RatioValuation
37.5x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
4.5%3/10

ROE of 4.5% — below average capital efficiency

EPS GrowthGrowth
-22.2%2/10

Earnings declined 22.2%

STXS4 concerns · Avg: 3.3/10
Price/BookValuation
13.4x4/10

Trading at 13.4x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$174.08M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-143.6%2/10

ROE of -143.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Debt/Equity, Price/Book.

Bull Case : STXS

The strongest argument for STXS centers on Revenue Growth. Revenue growth of 36.3% demonstrates continued momentum. PEG of 1.31 suggests the stock is reasonably priced for its growth.

Bear Case : ALC

The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.

Bear Case : STXS

The primary concerns for STXS are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

ALC profiles as a value stock while STXS is a hypergrowth play — different risk/reward profiles.

STXS carries more volatility with a beta of 1.40 — expect wider price swings.

STXS is growing revenue faster at 36.3% — sustainability is the question.

ALC generates stronger free cash flow (489M), providing more financial flexibility.

Bottom Line

ALC scores higher overall (49/100 vs 34/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

Stereotaxis Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (MRI) systems for use in the hospital's interventional operating room to improve the treatment of arrhythmias and coronary artery disease in the United States and internationally. The company is headquartered in St. Louis, Missouri.

Want to dig deeper into these stocks?